Featured Article

Xylem Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD December 17, 2024

Xylem, a global water treatment company, had a positive Q3 2024. Revenue rose 1.3 % to $2.1 billion and earnings before interest and taxes rose 47% to $280 million over the same period last year. A review of Xylem’s 31 October 2024 earnings call and associated financial reports provided insight regarding the importance of pricing on performance. Mathew Pine, the CEO of Xylem since January this year, was proud of his team’s…

Read More

In This Issue

Charles River Laboratories Pricing Spineometer: 1 of 5 Vertebrae

By Tim J. Smith, PhD July 31, 2023

Charles River Laboratories, a research and development support services company to pharmaceutical and gene therapy biotech companies, had a positive Q1 2023.…

Read More

DXC Technology Pricing Spineometer: 3 of 5 Vertebrae

By Tim J. Smith, PhD July 31, 2023

DXC Technology, a global technology and IT services company with over 130,000 employees, had a lackluster Q4 2023. Revenue decreased 10% to…

Read More

Generac Pricing Spineometer: 2 of 5 Vertebrae

By Tim J. Smith, PhD July 31, 2023

Generac, a backup power generation company, had a problematic Q1 2023. Revenue fell 21% to $887 million while earnings before interest and…

Read More

WestRock Pricing Spineometer: 4 of 5 Vertebrae

By Tim J. Smith, PhD July 31, 2023

WestRock, a corrugated packaging company, had a challenging Q2 2023. Revenue decreased 1.9% to $5.3 billion while earnings before interest and taxes…

Read More

WIGLAF, STRAIGHT
TO YOUR INBOX